- Report
- March 2024
- 180 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- February 2021
- 345 Pages
Global
From €3606EUR$3,750USD£3,093GBP
- Report
- April 2020
- 269 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- April 2023
- 115 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- November 2021
- 109 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- June 2023
- 90 Pages
Global
From €3500EUR$3,899USD£3,108GBP
Levitra is a drug used to treat erectile dysfunction (ED) and is part of the Sexual and Reproductive Health Drugs market. It is a phosphodiesterase type 5 inhibitor (PDE5) that works by increasing blood flow to the penis during sexual stimulation. Levitra is available in tablet form and is taken orally. It is usually taken 30 minutes before sexual activity and can last up to 4 hours. Levitra is available in different strengths and is prescribed by a doctor.
Levitra is one of the most popular ED drugs on the market and is used by millions of men worldwide. It is generally well tolerated and has fewer side effects than other ED drugs. Levitra is also used to treat other conditions such as pulmonary arterial hypertension and benign prostatic hyperplasia.
The Sexual and Reproductive Health Drugs market is highly competitive and includes a number of companies such as Pfizer, Bayer, Eli Lilly, and GlaxoSmithKline. These companies are constantly innovating and developing new drugs to meet the needs of patients.
Some of the companies in the Levitra market include Pfizer, Bayer, Eli Lilly, GlaxoSmithKline, and Teva Pharmaceuticals. Show Less Read more
